INSIGHTS ON LIQUID DOSE MANUFACTURING

• Isolator Air Handling: Advancements And Considerations For Fill-Finish Processing

  When it come to fill-finish manufacturing of parenteral liquid pharmaceuticals, your choice of barrier technology is crucial.

• A Standardized Gloveless Robotic Isolator

  By eliminating human intervention—the primary risk factor compromising drug sterility and quality—gloveless aseptic processing technology offers manufacturers greater flexibility, safety, and regulatory compliance in their filling operations.

• Formulation Development For Therapeutic Oligonucleotides

  Discover how expert formulation and analytical support enable the development of stable, injectable oligonucleotide therapies across diverse delivery routes and molecule types.

• Demystifying Lyophilization: Understanding The Freeze-Drying Process

  Advancements in lyophilization technology and research have helped overcome inherent challenges and ensure the safety and efficacy of lyophilized pharmaceuticals.

• Expanding The Viscosity Limits Of Peristaltic Dosing

  12/17/2025

  Discover how innovations in closed-loop control and mechanical design extend peristaltic dosing limits to 2000 cP, maintaining accuracy while preserving the advantages of sterile, disposable paths.

• Meet Regulation Requirements With RTU Vials And Cartridges

  10/9/2025

  Sterile manufacturing remains vital, with resilient supply chains preventing shortages. Industry and regulators prioritize integrity as demand surges, making it the fastest-growing pharmaceutical segment.

• What Is Aseptic Processing?

  1/9/2026

  Aseptic processing sterilizes products and packaging separately, then combines them in a sterile environment. See how this method ensures safety, extends shelf life, and protects medicines from contamination.

• Fill-Finish Contract Manufacturing: Trends, Challenges, And The Future

  9/16/2025

  See why it's important to partner with a CDMO that’s investing in advanced sterile fill-finish capabilities to meet the demands of complex biologics, gene therapies, and mRNA-based products.

• Navigating The New USP Chapter <382> For Elastomeric Closures

  6/24/2025

  Dive into the scope of <382> for pharmaceutical closures and the regulatory landscape, which includes new required tests, instrumentation for compliance, and recommendations on implementation.